Want to see IN:TTKHLTCARE full AI Analyst Report?
TTKHLTCARE Stock Chart & Stats
₹1082.70
-₹40.65(-3.73%)
At close: 4:00 PM EDT
₹1082.70
-₹40.65(-3.73%)
Day’s Range― - ―
52-Week Range₹737.00 - ₹1,255.00
Previous CloseN/A
Volume18.95K
Average Volume (3M)82.00
Market Cap
₹15.49B
Enterprise Value₹1.34K
Total Cash (Recent Filing)₹9.36B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)20.8
Beta0.79
Next Earnings
Oct 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.91%
Share Statistics
EPS (TTM)52.34
Shares Outstanding14,130,333
10 Day Avg. Volume50
30 Day Avg. Volume82
Financial Highlights & Ratios
PEG Ratio-0.86
Price to Book (P/B)0.99
Price to Sales (P/S)1.29
P/FCF Ratio-41.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very Low LeverageMinimal leverage reduces solvency risk and interest burden, giving TTK Healthcare greater flexibility to fund operations, product development, and distribution expansion without depending heavily on external financing.
Growing Asset And Equity BaseA steadily expanding equity and asset base indicates accumulated financial resources and supports the company’s ability to maintain manufacturing capacity, serve institutional customers, and invest in its healthcare portfolio over time.
Diversified Healthcare Portfolio And ChannelsExposure to both branded consumer healthcare and medical devices, sold through retail and institutional channels, diversifies revenue sources and can reduce dependence on any single product category or customer segment.
Bears Say
Sustained Negative Cash FlowPersistent cash burn despite reported profitability weakens cash conversion and financial flexibility. If working-capital or investment demands remain elevated, the company may have less capacity to fund growth internally.
Recent Margin CompressionThe latest margin decline suggests pressure from product mix, input costs, pricing, or operating leverage. Sustained compression could reduce the earnings benefit of revenue growth and weaken returns on the expanding asset base.
Slowing Revenue GrowthDecelerating revenue growth indicates that market expansion or product adoption has moderated. Unless new products, stronger distribution, or channel gains restore momentum, slower top-line growth may constrain operating leverage and profit growth.
TTK Healthcare Limited News
TTKHLTCARE FAQ
What was TTK Healthcare Limited’s price range in the past 12 months?
TTK Healthcare Limited lowest stock price was ₹737.00 and its highest was ₹1255.00 in the past 12 months.
What is TTK Healthcare Limited’s market cap?
TTK Healthcare Limited’s market cap is ₹15.49B.
When is TTK Healthcare Limited’s upcoming earnings report date?
TTK Healthcare Limited’s upcoming earnings report date is Oct 23, 2026 which is in 57 days.
How were TTK Healthcare Limited’s earnings last quarter?
TTK Healthcare Limited released its earnings results on Aug 06, 2026. The company reported ₹15.059 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is TTK Healthcare Limited overvalued?
According to Wall Street analysts TTK Healthcare Limited’s price is currently Overvalued.
Does TTK Healthcare Limited pay dividends?
TTK Healthcare Limited pays a Annually dividend of ₹10 which represents an annual dividend yield of 0.91%. See more information on TTK Healthcare Limited dividends here
What is TTK Healthcare Limited’s EPS estimate?
TTK Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TTK Healthcare Limited have?
TTK Healthcare Limited has 14,130,333 shares outstanding.
What happened to TTK Healthcare Limited’s price movement after its last earnings report?
TTK Healthcare Limited reported an EPS of ₹15.059 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.538%.
Which hedge fund is a major shareholder of TTK Healthcare Limited?
Currently, no hedge funds are holding shares in IN:TTKHLTCARE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
TTK Healthcare Limited
TTK Healthcare Limited is a diversified enterprise operating across multiple sectors in India and globally. Its extensive activities encompass animal welfare, offering veterinary therapeutic solutions and feed supplements. The human pharmaceuticals division provides a range of herbal and allopathic formulations. Within consumer products, the company is responsible for marketing and distributing items such as Woodward's Gripewater, the EVA cosmetics line, and Good Home scrubbers and air fresheners. Its medical devices segment manufactures and supplies artificial heart valves, in addition to developing orthopedic implants and surgical instruments. Furthermore, TTK Healthcare produces and markets protective devices, including male contraceptives. The food segment specializes in manufacturing and selling processed food items like potato and cereal-based pellets. Notably, the company also engages in map and atlas printing and publishing through its 'Others' segment. Founded in 1958 and headquartered in Chennai, India, TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd.
Technical Analysis
Abbott India Limited
―
Cipla Ltd
―
GlaxoSmithKline Pharmaceuticals Limited
―
Sanofi India Limited
―
Sanofi Consumer Healthcare India Limited
―